| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013830291 |
| P356 | DOI | 10.1186/1757-2215-3-13 |
| P932 | PMC publication ID | 2890636 |
| P698 | PubMed publication ID | 20504359 |
| P5875 | ResearchGate publication ID | 44632087 |
| P2093 | author name string | John M Daly | |
| M Alexandra Monroy | |||
| Smitha Yerrum | |||
| James J Rough | |||
| P2860 | cites work | Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway | Q24316367 |
| LXR, a nuclear receptor that defines a distinct retinoid response pathway | Q24317347 | ||
| A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily | Q24609094 | ||
| CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 | ||
| Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist | Q28250185 | ||
| Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells | Q28291080 | ||
| Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation | Q28647313 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Nuclear receptors and lipid physiology: opening the X-files | Q29619362 | ||
| Effects of diallyl disulfide (DADS) on expression of apoptosis associated proteins in androgen independent human prostate cancer cells (PC-3). | Q33365062 | ||
| Frequency of symptoms of ovarian cancer in women presenting to primary care clinics | Q33978981 | ||
| Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. | Q34311566 | ||
| Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation | Q35912822 | ||
| Liver X receptors as integrators of metabolic and inflammatory signaling | Q36411128 | ||
| The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer | Q36714706 | ||
| The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells | Q37219788 | ||
| Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses | Q40086076 | ||
| The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression | Q40218920 | ||
| Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug | Q43606252 | ||
| A sharper image of SHP. | Q44085594 | ||
| The nuclear oxysterol receptor LXRalpha is expressed in the normal human breast and in breast cancer | Q45010443 | ||
| T0901317 is a dual LXR/FXR agonist | Q45089589 | ||
| Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. | Q50700201 | ||
| Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. | Q53227029 | ||
| Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells. | Q53580633 | ||
| T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR | Q80120308 | ||
| P921 | main subject | ovarian carcinoma | Q18556145 |
| P304 | page(s) | 13 | |
| P577 | publication date | 2010-05-26 | |
| P1433 | published in | Journal of Ovarian Research | Q27721898 |
| P1476 | title | Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells | |
| P478 | volume | 3 |
| Q28118739 | Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis |
| Q41888020 | Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells |
| Q38739920 | LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. |
| Q36244293 | Ligands of Therapeutic Utility for the Liver X Receptors |
| Q64235584 | Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro |
| Q37572922 | Liver X receptor agonist T0901317 reverses resistance of A549 human lung cancer cells to EGFR-TKI treatment |
| Q36545158 | Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression |
| Q33892325 | Liver X receptors alpha gene (NR1H3) promoter polymorphisms are associated with systemic lupus erythematosus in Koreans |
| Q37738095 | NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer |
| Q38123210 | Oxysterol receptors and their therapeutic applications in cancer conditions. |
| Q37376541 | RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer |
| Q35464846 | T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected] |
| Q38382991 | Targeting liver X receptors in cancer therapeutics |
| Q37825904 | Targeting liver X receptors in human health: deadlock or promising trail? |
| Q64097343 | The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway |
| Q38703765 | The emerging roles of liver X receptors and their ligands in cancer. |
Search more.